RAS(ON) Inhibitor Daraxonrasib Shows Promising Results in Advanced Pancreatic Cancer Phase 1/2 Study...Dana-Farber Cancer Institute
Eric Miller, MD, PhD, principal investigator of the trial and associate professor of radiation oncology at The Ohio Stat...Alliance for Clinical Trials in Oncology
